GE HealthCare Partners with DocPanel for Advanced Cerianna Reader Training Program
GE HealthCare and DocPanel Collaboration for Advanced Training
In a significant move to enhance diagnostic accuracy in breast cancer treatment, GE HealthCare has announced its partnership with DocPanel Technologies. This collaboration aims to bolster clinician education through an advanced training program specifically for the Cerianna™ (fluoroestradiol F18) injection, a key tool in positron emission tomography (PET) imaging.
Understanding the Collaboration
DocPanel Technologies is a renowned radiology platform that connects healthcare providers with a vast network of U.S.-based, fellowship-trained radiologists. By leveraging this wide-ranging expertise, the partnership with GE HealthCare seeks to provide comprehensive support to healthcare professionals in their use of Cerianna™, which is instrumental in visualizing estrogen receptors in patients battling ER+ recurrent and metastatic breast cancer.
Dr. Jaideep Sohi, a Nuclear Medicine Physician at DocPanel and the leading figure in this initiative, emphasized the impact of this training program on clinical decision-making. He stated, "Imaging with Cerianna reflects the location of estrogen receptors as well as their ability to bind to estrogen, aiding clinicians in diagnosing and treating patients effectively. This partnership enables us to provide essential training to healthcare providers, helping them integrate this critical imaging agent into their practices."
Enhancing Diagnostic Confidence
The advanced reader training program will serve as a peer-to-peer educational initiative, where clinicians can receive guidance and support from experienced nuclear medicine specialists. The goal is to enhance diagnostic confidence, particularly in complex cases involving PET imaging with FES. The training sessions are designed to be flexible, accommodating the varied schedules of healthcare providers.
"At GE HealthCare, we strive to equip clinicians with not just the tools, but also the necessary training for delivering precise and effective care," said Mohamed Fouda, General Manager of Molecular Imaging in GE HealthCare's Pharmaceutical Diagnostics division in the U.S. and Canada. His remarks highlight GE HealthCare's commitment to improving patient care through innovative training solutions.
Benefits of the Program
Healthcare professionals interested in the Cerianna™ Reader Support program can register at no cost, a testament to the partnership's focus on accessibility and education. This initiative not only provides valuable resources to clinicians but also ensures that patients benefit from improved diagnostic accuracy and treatment strategies.
Beyond just education, the collaboration allows for the integration of cutting-edge imaging techniques into clinical practice, further ensuring that both patients and their healthcare providers are equipped with the most current tools and knowledge.
About the Key Players
DocPanel Technologies
DocPanel is recognized as a leading radiology platform, merging technology with medical expertise to connect healthcare professionals with a comprehensive network of radiologists. The company aims to enhance access to subspecialty radiology, ensuring that high-quality imaging services are available worldwide.
GE HealthCare
As a frontrunner in healthcare innovation, GE HealthCare has been a trusted partner in the global medical community for over 125 years. The organization focuses on developing advanced medical technology, including pharmaceutical diagnostics and integrated healthcare solutions that aim to enhance operational efficiency within healthcare systems.
For further information on how to utilize DocPanel's expertise or to register for the Cerianna™ Reader Support Program, interested parties can reach out to Ami Cohen.
In conclusion, this partnership between GE HealthCare and DocPanel signifies a promising step towards advancing the education and training of healthcare professionals, directly influencing the quality of care and outcomes for patients with breast cancer. As imaging technology continues to evolve, collaborative efforts like this will be essential in ensuring that clinicians remain at the forefront of innovative, compassionate care.